PNGAF (The Precision Peptide Co) Research & Development: $0.03 Mil (TTM As of Jan. 2026)


PNGAF The Precision Peptide Co Inc PNGAF
21 GF Score
Price $0.34
! 4 Warning Signs
View Full Analysis

What is The Precision Peptide Co Research & Development?

The Precision Peptide Co PNGAF -1.93% 21 Research & Development is $0.03 Mil as of Jan. 2026. GuruFocus rates PNGAF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. The Precision Peptide Co's Research & Development for the three months ended in Jan. 2026 was $0.03 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 was $0.03 Mil.

The Precision Peptide Co  (OTCPK:PNGAF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

The Precision Peptide Co Research & Development Related Terms

The Precision Peptide Co Research & Development Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co Research & Development Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
Research & Development
0.00 0.00 0.00 0.02 0.02

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.03
PNGAF
21GF Score
The Precision Peptide Co Inc PNGAF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.03 Mil mean?
The Precision Peptide Co (PNGAF) has a Research & Development of $0.03 Mil as of Jan. 2026. Research and development expense is the total cost for research and development activities. View historical data on The Precision Peptide Co and its competitors.
Is The Precision Peptide Co's Research & Development too high?
The Precision Peptide Co's current Research & Development is $0.03 Mil. Overall, The Precision Peptide Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's Research & Development compare to KHC and GIS?
The Precision Peptide Co's Research & Development of $0.03 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on The Precision Peptide Co and its competitors. The Precision Peptide Co's current Research & Development is $0.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current Research & Development of $0.03 Mil. The current Research & Development is $0.03 Mil. The Precision Peptide Co's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current Research & Development is $0.03 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges XU0:GermanyBPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
21GF Score

Get the complete analysis for PNGAF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price